Loading clinical trials...
Loading clinical trials...
The Predictive Values of Rapid Virus Response and Complete Early Virus Response for Sustained Virus Response in Chronic Hepatitis C Treated With Individual Therapeutic Programme
Conditions
Interventions
Pegylated interferon alfa-2a and ribavirin
Locations
1
China
Beijing Ditan hospital,Capital Medical University
Beijing, Beijing Municipality, China
Start Date
January 1, 2004
Primary Completion Date
May 1, 2011
Completion Date
September 1, 2011
Last Updated
September 27, 2016
NCT00199719
NCT06922643
NCT03612973
NCT01866930
NCT05895448
NCT02219490
Lead Sponsor
Beijing Ditan Hospital
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions